<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01941875</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00032793</org_study_id>
    <nct_id>NCT01941875</nct_id>
  </id_info>
  <brief_title>Luteal Phase Progesterone in IUI and Gonadotropin Cycles</brief_title>
  <official_title>The Effect of Luteal Phase Support on Pregnancy Rate in Intrauterine Insemination Cycles Following Ovarian Stimulation With Gonadotropins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of patients undergoing Controlled Ovarian Hyperstimulation (COH) with
      Gonadotropins and Intrauterine Insemination (IUI) at a Fertility Clinic.

      Infertility is a common problem, and a popular method of therapy is to inject sperm through
      the cervix and into the uterus, a procedure known as IUI. In conjunction with IUI, injectable
      medications (gonadotropins) are used to stimulate the ovaries to produce more than one egg
      per cycle in a process called COH.

      Vaginal progesterone is used for luteal support in in vitro fertilization therapy and has
      been proven to effect pregnancy rates. However, the role of progesterone in COH is still
      unclear. In this study, the investigators want to examine the effect of giving vaginal
      progesterone after COH with IUI on pregnancy rates. The investigators want to study if luteal
      vaginal progesterone results in a higher pregnancy rate compared to no progesterone therapy
      in COH with IUI. At present, fertility centres vary in the use of progesterone after
      insemination, most likely due to the lack of studies on this subject.

      At the Fertility Clinic all patients undergoing COH with injectable medications and IUI,
      regardless of whether they are in the study, have a baseline transvaginal ultrasound and
      blood tests. Patients start the injectable medications for COH until the ovarian follicles
      are large enough, then a medication to release the eggs is given. The IUI is done
      approximately 36 hours later. The day after the IUI, study patients will be given vaginal
      progesterone while the control patients will receive no progesterone. All patients will be
      followed until a pregnancy test is done and a viable foetus is confirmed by ultrasound.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>After 6 weeks gestational age</time_frame>
    <description>Presence of a fetal heart beat after 6 weeks gestational age</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical Pregnancy</measure>
    <time_frame>After 6 weeks gestational age</time_frame>
    <description>Biochemical pregnancy rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-viable Pregnancy</measure>
    <time_frame>After 6 weeks gestational age</time_frame>
    <description>Non-viable pregnancy rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiple Pregnancy</measure>
    <time_frame>After 6 weeks gestational age</time_frame>
    <description>Multiple pregnancy rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>No Luteal Support</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group: No luteal phase support or medication will be used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Luteal Vaginal Progesterone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment group: Vaginal progesterone for luteal support beginning the first day after IUI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Progesterone Effervescent Vaginal Tablets</intervention_name>
    <description>Experimental</description>
    <arm_group_label>Luteal Vaginal Progesterone</arm_group_label>
    <other_name>Endometrin 100 mg twice daily</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Couples with infertility

          -  Confirmed bilateral tubal patency

          -  More than 10 million motile sperm available for IUI

        Exclusion Criteria:

          -  Subjects declining enrollment

          -  Allergies to prescribed vaginal progesterone

          -  Subjects less than 21 years old or over 43 years old
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tarek Motan, MB ChB</last_name>
    <phone>780-735-5604</phone>
    <email>tmotan@ualberta.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jinglan Han, MD</last_name>
    <phone>780-735-5604</phone>
    <email>jinglan@ualberta.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fertility &amp; Womens Endocrine Clinic, Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarek Motan, MB ChB</last_name>
      <phone>780-735-5604</phone>
      <email>tmotan@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jinglan Han, MD</last_name>
      <phone>780-735-5604</phone>
      <email>jinglan@ualberta.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Tarek Motan, MB ChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jinglan Han, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2013</study_first_submitted>
  <study_first_submitted_qc>September 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2013</study_first_posted>
  <last_update_submitted>December 31, 2014</last_update_submitted>
  <last_update_submitted_qc>December 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>controlled ovarian hyperstimulation</keyword>
  <keyword>gonadotropins</keyword>
  <keyword>intrauterine insemination</keyword>
  <keyword>infertility</keyword>
  <keyword>luteal progesterone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

